Prospect News: News for Talecris Biotherapeutics Holdings Corp.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with T > Issuers starting with T, BK only > All stories on Talecris Biotherapeutics Holdings Corp. > Stories on Talecris Biotherapeutics Holdings Corp., BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Talecris Biotherapeutics Holdings Corp.

7/21/2010	BKHY	Moody's puts Talecris on review
7/20/2010	BKHY	Moody's gives Grifols B1, loans Ba3, B3
6/7/2010	BKHY	Moody's: Talecris outlook at developing
3/17/2010	BKBWHY	Talecris' CEO says capital structure now supports long-term growth
10/14/2009	BKHY	Moody's raises Talecris, rates notes B1
10/13/2009	BK	Talecris amends revolver, permitting notes sale for loan repayments
9/15/2009	BK	Talecris to pay down first-, second-lien bank debt with IPO proceeds

©2026 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.